Results 231 to 240 of about 10,459,346 (392)

Managing Euro Risk: Saving Investors from Systemic Risk [PDF]

open access: yes, 2020
Blake, D., Lyddon, R., Reynolds, B.
core  

Sarilumab in Polyarticular‐Course Juvenile Idiopathic Arthritis: Dose‐Finding and One‐Year Analysis of a Phase 2b, Open‐Label, Multicenter Study

open access: yesArthritis Care &Research, Accepted Article.
Objective This study assessed sarilumab in treating patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods This phase 2b, open‐label study (NCT02776735) consisted of three sequential parts (each with a core‐treatment and extension‐phase). During part 1, three doses were assessed in two weight groups (Group A/B: ≥30–60 kg/≥10–<
Fabrizio De Benedetti   +19 more
wiley   +1 more source

Regulation Mechanism Of Systemic Risk In Agricultural Insurance

open access: hybrid, 2019
Alkhozur Kharonovich Tsakayev   +1 more
openalex   +1 more source

A Qualitative Analysis of Patient Perspectives and Preferences in Lupus Management to Guide Lupus Guidelines Development

open access: yesArthritis Care &Research, EarlyView.
Objective A patient‐centered approach for chronic disease management, including systemic lupus erythematosus (SLE), aligns treatment with patients’ values and preferences, leading to improved outcomes. This paper summarizes how patient experiences, perspectives, and priorities informed the American College of Rheumatology (ACR) 2024 Lupus Nephritis (LN)
Shivani Garg   +20 more
wiley   +1 more source

Systemic risk factors contributing to sialolithiasis: a big-data retrospective analysis. [PDF]

open access: yesClin Oral Investig
Jonas E   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy